Dr Marsha Diane Soni, MD | |
3700 Joseph Siewick Drive, Ste 209, Fairfax, VA 22033 | |
(703) 758-2664 | |
(703) 758-2668 |
Full Name | Dr Marsha Diane Soni |
---|---|
Gender | Female |
Speciality | Infectious Disease |
Experience | 40 Years |
Location | 3700 Joseph Siewick Drive, Fairfax, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619924347 | NPI | - | NPPES |
F0020002 | Other | DC | BCBS-DC/MD |
005806011 | Medicaid | VA | |
318573 | Other | MAMSI | |
2579779 | Other | AETNA HMO | |
2866927001 | Other | CIGNA | |
258947 | Other | ANTHEM | |
4303076 | Other | AETNA | |
9200049 | Other | UNITED HEALTH CARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 0101046884 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Caregivers Home Health Services, Inc | Falls church, VA | Home health agency |
Novant Prince William Medical Center | Manassas, VA | Hospital |
Reston Hospital Center | Reston, VA | Hospital |
Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
Stonesprings Hospital Center | Dulles, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Infectious Diseases Specialists Of Virginia, Llc | 5597747287 | 3 |
Infectious Diseases Specialists Of Virginia, Llc | 5597747287 | 3 |
News Archive
Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels. Inhibiting the formation of new blood vessels is an important aspect of, for example, cancer treatment. The study is published in the November issue of the journal Molecular Cancer Research.
More and more strains of bacteria are developing resistance to previously life-saving antibiotics. Researchers at TUM, the Technische Universitaet Muenchen, have shed light on a metabolic step that appears in many aggressive microorganisms - such as tuberculosis and malaria pathogens - and that may provide a promising target for a new class of antibiotics. The researchers present their results in the chemistry journal Angewandte Chemie.
Treating pre-hypertension with medication and lifestyle modifications reduces the risk of patients progressing to hypertension, a new study involving researchers at UT Southwestern Medical Center has concluded.
An international consortium of scientists, including major contributions from the Montreal Heart Institute, demonstrates that the "one-size fits all" strategy of uniformly doubling the dose of an antiplatelet drug, clopidogrel, for patients with high on-treatment platelet reactivity does not reduce the incidence on death, heart attacks and stent thrombosis after percutaneous coronary intervention.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
› Verified 5 days ago
Entity Name | Infectious Diseases Specialists Of Virginia, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336181882 PECOS PAC ID: 5597747287 Enrollment ID: O20040614001741 |
News Archive
Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels. Inhibiting the formation of new blood vessels is an important aspect of, for example, cancer treatment. The study is published in the November issue of the journal Molecular Cancer Research.
More and more strains of bacteria are developing resistance to previously life-saving antibiotics. Researchers at TUM, the Technische Universitaet Muenchen, have shed light on a metabolic step that appears in many aggressive microorganisms - such as tuberculosis and malaria pathogens - and that may provide a promising target for a new class of antibiotics. The researchers present their results in the chemistry journal Angewandte Chemie.
Treating pre-hypertension with medication and lifestyle modifications reduces the risk of patients progressing to hypertension, a new study involving researchers at UT Southwestern Medical Center has concluded.
An international consortium of scientists, including major contributions from the Montreal Heart Institute, demonstrates that the "one-size fits all" strategy of uniformly doubling the dose of an antiplatelet drug, clopidogrel, for patients with high on-treatment platelet reactivity does not reduce the incidence on death, heart attacks and stent thrombosis after percutaneous coronary intervention.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Marsha Diane Soni, MD 3700 Joseph Siewick Drive, Ste 209, Fairfax, VA 22033 Ph: (703) 758-2664 | Dr Marsha Diane Soni, MD 3700 Joseph Siewick Drive, Ste 209, Fairfax, VA 22033 Ph: (703) 758-2664 |
News Archive
Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels. Inhibiting the formation of new blood vessels is an important aspect of, for example, cancer treatment. The study is published in the November issue of the journal Molecular Cancer Research.
More and more strains of bacteria are developing resistance to previously life-saving antibiotics. Researchers at TUM, the Technische Universitaet Muenchen, have shed light on a metabolic step that appears in many aggressive microorganisms - such as tuberculosis and malaria pathogens - and that may provide a promising target for a new class of antibiotics. The researchers present their results in the chemistry journal Angewandte Chemie.
Treating pre-hypertension with medication and lifestyle modifications reduces the risk of patients progressing to hypertension, a new study involving researchers at UT Southwestern Medical Center has concluded.
An international consortium of scientists, including major contributions from the Montreal Heart Institute, demonstrates that the "one-size fits all" strategy of uniformly doubling the dose of an antiplatelet drug, clopidogrel, for patients with high on-treatment platelet reactivity does not reduce the incidence on death, heart attacks and stent thrombosis after percutaneous coronary intervention.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
› Verified 5 days ago
Shivangi Vachhani, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 3700 Joseph Siewick Dr Ste 408a, Fairfax, VA 22033 Phone: 877-511-4625 Fax: 703-204-9006 | |
Dr. Raymund S Cuevo, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-4724 Fax: 571-472-0241 | |
Dr. Michael Maitland, M.D., PH.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-4724 Fax: 571-472-1601 | |
Dr. Paul G. Rochmis, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3027 Javier Rd, Suite 2, Fairfax, VA 22031 Phone: 703-573-2220 Fax: 703-573-7767 | |
Aswani Kumar Suthrave, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3600 Joseph Siewick Dr, Fairfax, VA 22033 Phone: 703-391-3600 | |
Nader H Balba, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3028 Javier Rd Ste 500, Fairfax, VA 22031 Phone: 703-698-8960 Fax: 571-494-5794 | |
Rona Harthill Earle, Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3020 Hamaker Ct Ste B102, Fairfax, VA 22031 Phone: 703-573-4072 Fax: 703-572-2153 |